Barclays’s CareMax, Inc. Class A Common Stock CMAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-692
| Closed | -$7 | – | 5710 |
|
|
2024
Q4 | $7 | Sell |
692
-97
| -12% | -$155 | ﹤0.01% | 5231 |
|
|
2024
Q3 | $1.34K | Sell |
789
-84
| -10% | -$256 | ﹤0.01% | 5109 |
|
|
2024
Q2 | $2.44K | Sell |
873
-1,277
| -59% | -$3.99K | ﹤0.01% | 4628 |
|
|
2024
Q1 | $10.4K | Sell |
2,150
-1,972
| -48% | -$16.6K | ﹤0.01% | 4808 |
|
|
2023
Q4 | $61.6K | Buy |
4,122
+3,004
| +269% | +$125K | ﹤0.01% | 4738 |
|
|
2023
Q3 | $71.1K | Sell |
1,118
-71
| -6% | -$4.97K | ﹤0.01% | 3715 |
|
|
2023
Q2 | $111K | Sell |
1,189
-480
| -29% | -$42.3K | ﹤0.01% | 3516 |
|
|
2023
Q1 | $134K | Buy |
1,669
+471
| +39% | +$55K | ﹤0.01% | 4025 |
|
|
2022
Q4 | $131K | Buy |
1,198
+65
| +6% | +$9.72K | ﹤0.01% | 4070 |
|
|
2022
Q3 | $241K | Buy |
1,133
+685
| +153% | +$138K | ﹤0.01% | 3101 |
|
|
2022
Q2 | $49K | Buy |
448
+99
| +28% | +$17K | ﹤0.01% | 4045 |
|
|
2022
Q1 | $78K | Buy |
+349
| New | +$72.4K | ﹤0.01% | 3908 |
|
Barclays's CMAX Position: Q1 2025 in Review
Barclays sold out of CareMax, Inc. Class A Common Stock (CMAX) in Q1 2025, closing a stake of 692 shares — an estimated $7 sold.
Barclays first reported a position in CMAX in Q1 2022 and held it in 12 quarters. The position peaked at $241K in Q3 2022. 0 funds tracked by Wall St. Rank hold CMAX as of Q1 2025.
- Barclays reported no remaining CareMax, Inc. Class A Common Stock position as of Q1 2025 after selling out during the quarter.
- Barclays sold 692 CareMax, Inc. Class A Common Stock shares in Q1 2025, an estimated $7.
- Barclays first reported a position in CareMax, Inc. Class A Common Stock in Q1 2022 and held it in 12 quarters.
- Barclays's CareMax, Inc. Class A Common Stock position peaked at $241K in Q3 2022.
- 0 funds tracked by Wall St. Rank held CareMax, Inc. Class A Common Stock as of Q1 2025.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.